PTPRC and cancer: We investigated neutrophils (CD45+ CD66b+), CD8+ T cells (CD3+CD8+), and CD4+ T cells (CD3+CD4+) in addition to PD-1 and PD-L1 expression in 25 tissue samples that were available from the cancer cohort (Figure 4A).